☆ 4.6 Letter

Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism

LANCET DIABETES & ENDOCRINOLOGY (2021)

Get Full Text
Add to Collection

Journal

LANCET DIABETES & ENDOCRINOLOGY
Volume 9, Issue 4, Pages 197-199

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S2213-8587(21)00028-0

Keywords

-

Categories

Endocrinology & Metabolism

Funding

  1. Menarini Pharmaceuticals
  2. LEO Pharma

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.